Additionally, it controls epithelial-mesenchymal transition to suppress proliferation and metastasis in ovarian cancer [18] and hampers malignant transformation in NSCLC via the miR-141-3p/LatS2 axis [28] and the miR-1278/SOCS6 axis [17]. The gene discussed is LATS2; the disease is ovarian cancer.